Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension

Published:2011-04 Issue:7 Volume:107 Page:1028-1033
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Huang Chin-Chou,Chan Wan-Leong,Chen Yu-Chun,Chen Tzeng-Ji,Lin Shing-Jong,Chen Jaw-Wen,Leu Hsin-Bang

Funder

Taipei Veterans General Hospital

Yen Tjing Ling Medical Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Angiotensin II type 1 receptor blockers;Burnier;Circulation,2001

2. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both;Pfeffer;N Engl J Med,2003

3. Telmisartan, ramipril, or both in patients at high risk for vascular events;Yusuf;N Engl J Med,2008

4. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial;Granger;Lancet,2003

5. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial;Yusuf;Lancet,2008

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis;Journal of Personalized Medicine;2023-01-29

2. Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment;Biomedicines;2022-11-21

3. Rare variant of Remkheld syndrome;Experimental and Clinical Gastroenterology;2022-01-16

4. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cancer Risk: An Updated Meta-Analysis of Observational Studies;SSRN Electronic Journal;2022

5. Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study;PLOS ONE;2021-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3